Cases 11 - 20 of 74
Gilead Sciences, Inc. et al v. Lupin Limited et al
as 1:2023cv00508
Plaintiff:
Gilead Sciences, Inc., Gilead Sciences Ireland UC, Janssen Products, L.P. and others
Defendant:
Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Amgen Inc. et al v. MSN Laboratories Private Limited et al
as 1:2023cv00031
Plaintiff:
Amgen Inc. and KAI Pharmaceuticals, Inc.
Defendant:
MSN Laboratories Private Limited, MSN Pharmaceuticals Inc. and MSN Life Sciences Private Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Taiho Pharmaceutical Co., Ltd. et al v. MSN Laboratories Private Ltd. et al
as 1:2023cv00008
Plaintiff:
Taiho Pharmaceutical Co., Ltd. and Taiho Oncology, Inc.
Defendant:
MSN Laboratories Private Ltd. and MSN Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AbbVie Inc. et al v. Alkem Laboratories Limited et al
as 1:2022cv01423
Plaintiff:
AbbVie Inc., AbbVie Ltd. and Neurocrine Biosciences, Inc.
Defendant:
Alkem Laboratories Limited, Hetero Labs Limited, Hetero Labs Limited Unit-V and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation v. Alembic Pharmaceuticals Limited et al
as 1:2022cv01395
Plaintiff:
Novartis Pharmaceuticals Corporation
Defendant:
Alembic Pharmaceuticals Limited, Alembic Global Holding SA, Alembic Pharmaceuticals, Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ACADIA Pharmaceuticals Inc. v. MSN Laboratories Private Limited et al
as 1:2022cv01388
Plaintiff:
ACADIA Pharmaceuticals Inc.
Defendant:
MSN Laboratories Private Limited and MSN Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Eli Lilly and Company et al v. MSN Laboratories Private Limited et al
as 1:2022cv01115
Plaintiff:
Eli Lilly and Company, Incyte Corporation and Incyte Holdings Corporation
Defendant:
MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc. and MSN Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Exelixis, Inc. v. MSN Laboratories Private Limited et al
as 1:2022cv00945
Plaintiff:
Exelixis, Inc.
Defendant:
MSN Laboratories Private Limited and MSN Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Otsuka Pharmaceutical Co., Ltd. v. MSN Laboratories Private Limited et al
as 1:2022cv00316
Plaintiff:
Otsuka Pharmaceutical Co., Ltd.
Defendant:
MSN Laboratories Private Limited and MSN Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Exelixis, Inc. v. MSN Laboratories Private Limited et al
as 1:2022cv00228
Plaintiff:
Exelixis, Inc.
Defendant:
MSN Laboratories Private Limited and MSN Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
